Summit Therapeutics
SMMT
#2244
Rank
A$12.02 B
Marketcap
A$15.03
Share price
-5.87%
Change (1 day)
-40.03%
Change (1 year)

Earnings for Summit Therapeutics (SMMT)

Earnings in 2026 (TTM): -A$1.22 Billion

According to Summit Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$1.64 Billion a decrease over its 2024 earnings that were of -A$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Summit Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$1.22 Billion-25.63%
2025 -A$1.64 Billion387.84%
2024 -A$0.34 Billion-64.01%
2023 -A$0.93 Billion680.54%
2022 -A$0.12 Billion-11.08%
2021 -A$0.14 Billion67.46%
2020 -A$79.94 Million29.71%
2019 -A$61.63 Million
2014 -A$48.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-A$0.2 Billion-84.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-A$3.42 Million-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
-A$0.23 Billion-81.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-A$0.95 Billion-24.71%๐Ÿ‡บ๐Ÿ‡ธ USA